Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 456
Immune Disorders Drugs 193
Cardiovascular Drugs 157
Drug Discovery 148
Infectious Diseases Drugs 132
Biopharmaceuticals 127
Endocrine and Metabolic Disorders Drugs 111
Clinical Trials 106
Central Nervous System Drugs 105
Musculoskeletal Disorders Drugs 96
Pharmaceuticals 95
Leukemia Drugs 80
Hematological Drugs 77
Liver and Kidney Disorders Drugs 75
Lymphoma Drugs 62
Diabetes Drugs 57
Dermatological Drugs 57
Skin Cancer Drugs 48
Brain Cancer Drugs 46
Respiratory Drugs 45
Mental Disorders Drugs 43
Lung Cancer Drugs 39
Gastrointestinal Drugs 38
Pharmaceutical Intermediates 34
Drug Delivery 33
Immunosuppressive Drugs 33
Pharmaceutical Manufacturing 31
Infusions and Injectables 30
Liver Cancer Drugs 29
Analgesics 27
Antibiotics 26
Bladder Cancer Drugs 25
Drugs by Therapeutic Area 23
Kidney Cancer Drugs 21
Pancreatic Cancer Drugs 19
Prostate Cancer Drugs 18
HIV/AIDS Drugs 18
Urological Disorders Drugs 18
Colon Cancer Drugs 17
Schizophrenia Drugs 17
Cervical Cancer Drugs 16
Sexual and Reproductive Health Drugs 16
Ovarian Cancer Drugs 15
Thyroid Cancer Drugs 14
Breast Cancer Drugs 13
Cancer Vaccines 13
Psoriasis Drugs 12
Over the Counter (OTC) Drugs 11
Biosimilars and Biosuperiors 11
Generic Drugs 10
Anti-Obesity Drugs 9
Optical Disorders Drugs 8
Vaccines 8
Transdermal and Transmucosal Drug Delivery 7
Alzheimer's Disease Drugs 7
Uterine Cancer Drugs 6
Company Reports 5
Cough and Cold Drugs 5
Anxiety Drugs 4
Pharmacoeconomics 3
Vitamins and Dietary Supplements 3
Asthma Drugs 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Allergy Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



278 reviews

2,402 Results (Page 23 of 121)
- Relevance
  Sort by

Critical Care Therapeutics - Global Strategic Business Report

 Report
August 2025
280 Pages
Global

From

€5207EUR$5,850USD£4,499GBP

Antivirals Drug - Global Strategic Business Report

 Report
August 2025
172 Pages
Global

From

€5207EUR$5,850USD£4,499GBP

Squamous Non-Small Cell Lung Cancer Therapeutics Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

 Report
October 2024
99 Pages
Global

From

€3500EUR$4,212USD£3,130GBP

Glioblastoma Multiforme Therapeutics Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
January 2024
78 Pages
Global

From

€3500EUR$4,212USD£3,130GBP

Liver Fibrosis Drugs Market by Drug Class (Biologic Therapies, Cell Therapies, Gene Therapies), Mechanism Of Action (ASK1 Inhibitors, Galectin-3 Inhibitors, PPAR Agonists), Route Of Administration, Distribution Channel - Global Forecast 2025-2030

 Report
August 2025
196 Pages
Global

From

€3156EUR$3,545USD£2,726GBP

€3506EUR$3,939USD£3,029GBP

NEED HELP FINDING THE RIGHT PRODUCT? Craig will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Prescription Drugs - Global Strategic Business Report

 Report
August 2025
150 Pages
Global

From

€5207EUR$5,850USD£4,499GBP

Antiviral Drugs Market by Mechanism of Action, Target Indication, Type of Drug Target, Type of Therapy and Key Geographies: Industry Trends and Global Forecasts, 2022-2035

 Report
September 2022
194 Pages
Global

From

€4272EUR$4,799USD£3,691GBP

Antiviral Drugs Market Report 2022-2032

 Report
November 2022
285 Pages
Global

From

€4732EUR$5,502USD£3,950GBP

Cutaneous and Systemic Leishmaniasis - Global Strategic Business Report

 Report
August 2025
473 Pages
Global

From

€5207EUR$5,850USD£4,499GBP

Hospital Acquired Infection Treatment - Global Strategic Business Report

 Report
August 2025
194 Pages
Global

From

€5207EUR$5,850USD£4,499GBP

Cryptococcosis Treatment - Global Strategic Business Report

 Report
August 2025
193 Pages
Global

From

€5207EUR$5,850USD£4,499GBP

Anti-Infectives - Global Strategic Business Report

 Report
August 2025
116 Pages
Global

From

€5207EUR$5,850USD£4,499GBP

Cytomegalovirus (CMV) Treatment - Global Strategic Business Report

 Report
August 2025
384 Pages
Global

From

€5207EUR$5,850USD£4,499GBP

Oral Antivirals - Global Strategic Business Report

 Report
August 2025
380 Pages
Global

From

€5207EUR$5,850USD£4,499GBP

Pseudomonas Aeruginosa Infection Treatment - Global Strategic Business Report

 Report
August 2025
273 Pages
Global

From

€5207EUR$5,850USD£4,499GBP

Encephalitis Treatment - Global Strategic Business Report

 Report
August 2025
478 Pages
Global

From

€5207EUR$5,850USD£4,499GBP

Neglected Tropical Disease Treatment - Global Strategic Business Report

 Report
August 2025
294 Pages
Global

From

€5207EUR$5,850USD£4,499GBP

Cryptococcosis Therapeutics - Global Strategic Business Report

 Report
August 2025
473 Pages
Global

From

€5207EUR$5,850USD£4,499GBP

Cell Therapy Clinical Activity and Process Automation

 Report
July 2023
100 Pages
Global

From

€4317EUR$4,850USD£3,730GBP

Pharmaceutical Market Size, Share & Trends Analysis Report by Molecule Type, Product, Type, Disease, Age Group, Route of Administration, Distribution Channel, and Region with Growth Forecasts, 2025-2030

 Report
February 2025
250 Pages
Global

From

€5296EUR$5,950USD£4,576GBP

2,402 Results (Page 23 of 121)
- 1
- 21
- 22
- 23
- 24
- 25

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.